Author:
Tangri Navdeep,De Nicola Luca
Abstract
Chronic kidney disease (CKD) is a progressive condition that can lead to
kidney failure and the requirement for renal dialysis or transplantation. Early-stage
CKD is often missed because the disorder is initially asymptomatic; hence, many
patients with CKD already have symptomatic advanced disease (Stages G4–G5)
at the time of diagnosis. This is an important issue because the drugs available
for the treatment of CKD are most effective when given during the early stages of
the disease (Stages G1–G3). EMJ conducted interviews in July 2022 with two key
opinion leaders, Navdeep Tangri from the University of Manitoba, Winnipeg, Canada,
and Luca De Nicola from the University of Campania Luigi Vanvitell, Naples, Italy,
both of whom have a wealth of experience in the management of patients with CKD.
The experts provided important insights into the ongoing REVEAL-CKD study, which
was designed to explore the global prevalence of undiagnosed Stage G3 CKD. This
article describes the main findings of the REVEAL-CKD study published to date and
their implications. Possible approaches to improving the diagnosis of CKD are
also discussed.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献